If direct-to-consumer advertisements come to Europe: lessons from the USA

Lancet

Volumn 369, Issue 9562, 2007, Pages 704-706

  Metzl, Jonathan M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CONSUMER; DRUG INDUSTRY; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; EUROPE; MEDICAL PRACTICE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 33847164471     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60321-3     Document Type: Review

References (10)

1. Auton F. The advertising of pharmaceuticals direct to consumers: a critical review of the literature and debate. Int J Adver 23 (2004) 1-5
2. Hone F., and Benson R. DTC: European style. Pharm Exec 24 (2004) 96-102
3. Kravitz R., Epstein R., Feldman M., et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 293 (2005) 1995-2002
4. Angell M. The truth about the drug companies: how they deceive us and what to do about it (2004), Random House, New York 83
5. Hollon M. Direct-to-consumer advertising: a haphazard approach to health promotion. JAMA 293 (2005) 2030-2033
6. Weissman J., Blumenthal D., Silk A., Zapert K., Newman M., and Leitman R. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Aff (Millwood). Published online Feb 26, 2003. DOI:10.1377/hlthaff.w3.82
7. Metzl J. Prozac on the couch: prescribing gender in the era of wonder drugs (2003), Duke, Durham
8. Aikin K. Direct-to-consumer advertising of prescription drugs: physician survey (Jan 13, 2003). http://www.fda.gov/cder/ddmac/globalsummit2003/sld001.htm (accessed Feb 13, 2007).
9. Alexander-Banys B. Pharmaceutical company advertising practices: call to arms. J Pediatr Health Care 16 (2002) 49-50
10. Metzl J., and Angel J. Assessing the impact of SSRI antidepressants on popular notions of women's depressive illness. Soc Sci Med 58 (2004) 577-584